Milvexian: Data readout from P3 LIBREXIA-STROKE trial (NCT05702034) for secondary stroke prevention in 2026 (43rd Annual J.P. Morgan Healthcare Conference, Bristol-Myers Squibb) - Jan 13, 2025 - Data readout from P3 LIBREXIA-ACS trial (NCT05754957) for acute coronary syndrome in 2026 P3 data • Acute Coronary Syndrome • Cardiovascular • Ischemic stroke
|